Chapter 36: Blood Types, Transfusion, and Tissue and Organ Transplantation

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement, not replace, the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

You know, usually when we think about the human body, we picture it as this impenetrable fortress.

Right, like your skin is the wall.

Exactly.

Your skin is the wall, your immune system is the standing army, and their only job is to keep foreign invaders out.

It feels very clean, you know?

Very clearly defined.

Us versus them.

I mean, the boundary between self and non -self seems like it should be the most obvious thing in the world, but it really isn't.

No, it's not.

Because when you look closely at what actually runs through our veins, suddenly that fortress metaphor just, it starts to crumble.

It does.

The most dangerous threat to the body sometimes isn't a virus, it isn't a bacteria.

Sometimes it's a perfectly healthy human cell that just happens to be wearing the wrong uniform.

Yeah, it is the ultimate biological friendly fire incident.

And when the body attacks itself in this specific way, the destruction is incredibly precise and terrifyingly fast.

Welcome to this deep dive.

If you are a college student out there tackling medical physiology for the very first time, consider this session custom built for you.

We are getting right into it today.

We really are.

We're diving into the hidden wars happening inside our veins.

We want to see how a single mismatched drop of blood can trigger a systemic meltdown.

And how modern medicine manages to trick the immune system into accepting life -saving organ transplants.

Which is practically magic.

Seriously, we're going to unpack the specific mechanisms laid out in Chapter 36 of the Guyton Hall textbook of medical physiology.

We will explore how microscopic anatomy drives immune function, how that function leads to life or death outcomes, and ultimately how we try to manipulate it.

So to set the stage for all of this, we really need to establish what that uniform actually is.

On the surface of our red blood cells, there are at least 30 commonly occurring antigens.

30?

Wow.

Yeah.

And hundreds of other rare ones floating around.

But you don't need to memorize all of them.

You only need to focus your energy on the two heavyweights that cause the most severe explosive immune reactions.

Okay.

What are they?

Those are the OAB system and the RH system.

So if our own cells can become the enemy, what exactly determines the uniform a cell wears?

I mean, it all has to start with the genetic blueprints, right?

It absolutely does.

Everything that happens in a hospital room during a transfusion starts at the genetic locus.

The genetic locus for the OAB blood group has three different alleles, which are just variations of the same gene.

Okay.

We have IA, IB, and IO.

And by the way, that capital I stands for immunoglobulin.

What's crucial here is how these three alleles interact with each other.

How do they?

Well, the AMB alleles are codominant.

That means if they are present in your DNA, they're absolutely going to produce strong antigens on the surface of your red blood cells.

And those physical antigens are formerly called agglutinogens, right?

Exactly.

But the O allele is completely recessive.

It produces no significant antigens at all.

Okay.

Let's unpack this with a visual.

If these alleles are like blueprints for building cell surface structures, it sounds like A and B build these highly specific prominent towers on the surface of the cell.

I love that analogy.

But O just leaves an empty lot.

There's no tower built there at all.

That is a brilliant way to look at it.

And because we inherit one chromosome from each parent, we get two of these blueprints.

Okay.

So that gives us what?

Six possible genetic combinations?

Right.

Six possible genotypes.

If you look at table 36 .1 in the text, you'll see them mapped out.

If you inherit two O alleles from your parents, you have genotype O.

So that leaves two empty lots.

Exactly.

No towers, no antigens.

That makes your blood type O.

But if you inherit an A and an O, that A tower still gets built, right?

Right.

Because the O is recessive.

Correct.

The A tower completely dominates the empty lot of the O.

So genotype OA results in type A blood.

And naturally, genotype AA also results in type A blood.

Makes sense.

It works the exact same way for B.

Genotypes OB and BB both give you type B blood.

And if you happen to inherit one A and one B...

Remember, they are codominant, neither backs down.

Both powers get built side by side on the cell surface.

That genotype is AB, giving you type AB blood.

If having an empty lot means having no antigens at all, is that rare?

Or is it pretty common to just have naked red blood cells?

It's actually the most common scenario by far.

About 47 % of the general population has type O blood.

Just empty lots.

Oh wow.

Almost half.

Type A is close behind at 41%.

Type B is much rarer at 9%.

And type AB, where you have both the A and B towers, is the absolute rarest at just 3%.

So that covers the anatomy of the red blood cell itself.

But if we want to understand why a transfusion reaction happens, we really have to look at the other half of the equation.

Right.

The environment they float in.

Exactly.

We have to transition from the antigens stuck to the cells, to the antibodies floating freely in the blood plasma.

Those plasma antibodies are known as agglutinins.

And the foundational rule of immunology here is surprisingly simple.

Which is?

Your body develops antibodies against whatever agglutinins you don't have.

Okay, let me think about that.

So if I am type O, and my cells are just empty lots, my immune system looks at both A towers and B towers as foreign invaders.

So type O plasma must contain both anti -A and anti -B agglutinins.

That's it, exactly.

If you have type A blood, your plasma has anti -B agglutinins.

If you have type B, you produce anti -A.

And if you are type AB...

Since both towers are already present on your own cells, your plasma has neither antibody.

If it did, your immune system would be constantly attacking your own blood.

But hold on, here is where it gets really interesting, and honestly a bit confusing.

If a person with type A blood has never received a type B transfusion in their entire life, why do they spontaneously have anti -B antibodies floating in their plasma?

That is the million dollar question.

Right, I mean where does that initial exposure come from if it isn't from a medical mistake?

Antibodies don't just appear out of nowhere.

There actually is exposure, but it's happening constantly in the background.

Small amounts of A and B antigens enter our bodies every single day.

Wait, how?

Through our food, through intestinal bacteria, and just through our environment.

These tiny unavoidable daily exposures are what actually initiate the development of those anti -A and anti -B agglutinins.

Wow, so our food and gut bacteria are essentially training our immune system to hate certain blood types.

Pretty much, yeah.

What does that timeline look like?

Are we born with these antibodies already?

No, not at all.

If you look at figure 36 .1 in the book, it maps out our immune defenses on a timeline over a person's life.

Okay, what does the graph show?

You'd see the concentration or the titer of agglutinins start at essentially zero immediately after birth.

A newborn just hasn't had time to eat solid food or be exposed to enough environmental bacteria yet.

That makes sense.

But at around two to eight months of age, the infant's immune system starts producing these agglutinins.

The curve rises sharply.

It peaks dramatically around eight to ten years of age.

And then what?

Does it stay that high forever?

No, then it gradually declines for the rest of the person's life.

And what exactly are these antibodies made of?

They are gamma globulins.

Specifically, they belong to the classes of immunoglobulins known as IgM and IgG.

Okay, so now we have our red blood cells with their antigen towers and our plasma filled with these IgM and IgG antibodies just patrolling the waters.

What is the physical mechanism when they clash?

When you mix anti -A or anti -B plasma agglutinins with red blood cells that have the matching A or B agglutinins, they bind together.

Like lock and key.

Exactly.

And this binding process is called agglutination.

In plain English, that literally means clumping.

Since we mentioned those specific immunoglobulins, let's visualize why that clumping happens so aggressively.

IgG has two binding sites, which is standard, but IgM has ten binding sites.

Right, it's massive.

So it's like throwing a multi -hooked grappling net into a massive crowd of cells.

A single IgM antibody grabs onto multiple red blood cells all at the same time, pulling them all together into a giant tangled cluster.

That is exactly what it looks like.

And those clusters are physically too large to pass through the circulatory system freely.

They act like biological debris, plugging up the small blood vessels throughout the body.

That sounds like a disaster.

It is.

During the next few hours today's, phagocytic white blood cells spot these distorted trapped cells.

They attack them, physically destroying their membranes.

Which spills everything inside.

Right, it releases the cells' hemoglobin directly into the plasma.

This delayed process of breaking down the red blood cells is called hemolysis.

But the textbook also mentions acute hemolysis, which sounds immediate and a lot more violent.

How does that happen?

Immediate intravascular hemolysis is rarer, but it is devastating.

It happens when there is a very high titer of specific IgM antibodies, which in this context are called hemolysins.

Instead of just clumping the cells together and waiting for white blood cells to clean up the mess, these hemolysins activate the body's complement system.

They form what is known as a membrane attack complex.

A membrane attack complex?

That sounds like it's literally punching holes in the lipid bilayer of the cell membrane.

That is exactly what it does.

It creates pores in the cell membrane that are highly permeable to ions.

Water rushes in through those pores, and the cell undergoes osmotic lysis.

So it just pops?

It explodes immediately, right there in the bloodstream, releasing all its contents.

So, to prevent this multi -hooked grappling net of destruction,

hospitals use blood typing.

And the actual lab process, outlined in table 36 .2, seems elegantly simple based on what we just learned.

It is incredibly straightforward.

Imagine you take a sample of a patient's red blood cells, separate them from the plasma, and dilute them with a saline solution.

Okay, got it.

Then you divide that sample into two batches.

You drop anti -A agglutin into one batch, and anti -B agglutin into the other.

And it's just a visual confirmation of the rules at that point.

Exactly.

If you watch the blood clump up in both batches, you know the cells have both antigens, so the patient is type AB.

If it clumps in neither batch, the cells have no antigens, they are empty lots.

So the patient is type O.

You got it.

It's a rapid physical test that prevents a catastrophic mismatch.

Right.

And that rapid test is what makes the OAB system manageable in modern medicine.

So the OAB system is a constant, everyday threat.

We are always primed to react.

But we mentioned there was a second heavy weight, the RH factor.

Yes, the RH system.

And then this textbook makes it clear that this acts more like a sleeper agent.

The RH system operates under a completely different set of rules.

Anatomically, there are six common types of RH antigens.

You have CC, D, D, D, E, and E.

Okay, so a few variations.

Right, but the D antigen is by far the most prevalent and the most highly antigenic.

If you have the D antigen on your red blood cells, you are designated as RH positive.

If you lack it, you are RH negative.

And demographically, how does that break down?

About 85 % of white people are RH positive.

It's about 95 % for black Americans.

And nearly 100 % of black Africans, Native Americans, and Asians are RH positive.

So it's just another antigen tower on the cell surface.

Why does the immune system treat it differently than the A or B towers?

The regulatory mechanism is totally different.

In the OAB system,

remember, antibodies develop spontaneously from everyday environmental exposure.

You are always armed.

Right, because of the gut bacteria.

Exactly.

But spontaneous anti -RH agglutinins almost never occur.

For an RH negative person to produce antibodies against the D antigen, they must be massively exposed to actual RH positive blood.

Wait, so if an RH negative person is in an accident, and they accidentally receive a transfusion of RH positive blood for the very first time,

nothing happens.

There's no immediate explosion.

Surprisingly, no.

The first exposure causes no immediate reaction because the antibodies simply aren't there yet.

But over the next two to four weeks, the immune system recognizes that foreign D antigen, it slowly starts producing anti -RH antibodies.

This causes a very mild delayed hemolysis of any transfused cells that are still circulating.

But the real danger is that the trap is now set.

Yes.

The patient is now permanently sensitized.

Their immune system remembers the D antigen.

So if it happens again?

If they ever receive a second transfusion of RH positive blood, the reaction will be delayed.

It will be immediate, severe, and potentially lethal, just like a mismatched OAB transfusion.

And this sensitization rule becomes critically important and incredibly tragic when we look at where the sleeper agent causes the most heartbreak,

pregnancy.

Yes, it's devastating.

The textbook refers to this condition as erythroblastosis fatalis, or hemolytic disease of the newborn.

This clinical scenario occurs when an RH negative mother carries an RH positive fetus.

The fetus inherited the D antigen from an RH positive father.

OK, so they have different blood types.

Right.

During that first pregnancy, the mother is usually exposed to small amounts of the fetal blood.

Especially during delivery.

That exposure sensitizes her immune system, but it happens too late to harm that first baby.

But the trap is set for the next child.

Sadly, yes.

By the time she gets pregnant with a second RH positive baby, her immune system is fully armed.

The incidence of the disease is 3 % for the second baby, and it rises to 10 % for the third.

And those antibodies can cross over?

Yes.

The mother's anti -RH antibodies are primarily IgG, which means they are small enough to diffuse directly across the placental membrane into the fetus's blood.

So the mother's immune system sends those grappling nets across the placenta, agglutinating and hemolyzing the baby's red blood cells while they are still developing in the room.

It's a horrific scenario.

What is the biological fallout of that for the baby?

The fallout is systemic and cascading.

As the baby's red blood cells are destroyed,

fetal macrophages swoop in to clean up the debris.

They convert all that released hemoglobin into a yellowish pigment called bilirubin.

Which causes jaundice, right?

Yes, it floods the baby's system, causing severe jaundice.

But worse, if that bilirubin precipitates in the neuronal cells of the brain, it can cause permanent motor damage.

It's a devastating condition known as kernicteris.

And I imagine the baby's body isn't just taking this without a fight.

The organs must be working overtime to replace the destroyed blood.

They're working in a state of absolute panic.

The baby's liver and spleen enlarge massively, desperately trying to pump out new red blood cells to keep oxygen flowing.

They pump them out so fast, acting like a wartime factory, that they start pushing out half -built, unfinished cells into the bloodstream.

Exactly.

These immature, nucleated forms of red blood cells are called blastic cells.

And that is exactly why the disease is called erythroblastosis fetalis.

The blood is filled with these blastic cells.

If a baby is born with this condition, the treatment involves slowly replacing the newborn's blood with Rh negative blood over several hours, sometimes repeating it over weeks.

To flush it out.

Right.

Wow.

This lowers the toxic bilirubin levels and buys time until the mother's antibodies eventually degrade and disappear from the baby's system.

But obviously modern medicine prefers to prevent this entirely.

The standard of care is that at 28 to 30 weeks of gestation, an Rh negative mother is administered an injection of Rh immunoglobulin.

The anti -antibody, yes.

But hold on, I am genuinely confused by this.

If the entire problem is that the mother's body is creating antibodies that kill the baby's cells, why on earth is the medical solution to inject her with an antibody?

Isn't that just adding fuel to the fire?

It sounds totally counterintuitive, I know.

But it is a brilliant biological sleight of hand.

The injection is an anti -D antibody.

When it enters the mother's bloodstream,

it hunts down any fetal D antigens that may have crossed the placenta.

But instead of triggering a massive immune response, it essentially coats and hides those fetal cells.

Oh, wow.

By masking the antigens, it prevents the mother's B lymphocytes from ever recognizing that a foreign invader is present.

Oh, I see.

So if her immune system never sees the antigen, it never gets triggered and it never builds its own permanent army of antibodies.

Precisely.

You're using a temporary antibody to stop the creation of a permanent one.

It is an incredibly elegant solution to a devastating problem.

That is fascinating.

Okay, I want to transition back to general mismatch transfusions in adults because there is a common point of confusion regarding the mechanics of a mismatch that we need to clear up.

Okay, let's do it.

Let's say I accidentally give type A donor blood to a type B recipient.

The recipient's anti -N antibodies will swarm and attack the donor cells.

That makes perfect sense.

But that donor blood also contains plasma, which means it contains anti -B antibodies.

Why don't the donor's antibodies attack the recipient's cells?

That comes down to the donor -recipient dilution rule.

Think about the volume.

You are only putting a pint or two of donor blood into an adult body that contains over a gallon of blood.

Right, it's a small fraction.

So the donor's plasma and the specific antibodies floating in it are immediately diluted by the recipient's entire massive blood volume.

The titer drops so low that the donor antibodies are basically harmless.

They just can't cause widespread damage.

But the recipient's antibodies are already at full strength.

Right, the recipient's antibodies are not diluted at all.

They remain highly concentrated and easily hunt down and destroy the small volume of incoming donor cells.

So when those donor cells are destroyed, what is the actual cause of death?

If the immune system wins the battle, why does the patient die?

The textbook points to acute kidney failure as the lethal endgame.

Yes, that is the ultimate failure point.

What exactly happens to the kidneys when massive hemolysis occurs?

When more than 400 milliliters of blood hemolyses in less than a day,

it releases an overwhelming amount of free hemoglobin into the plasma.

Normally, a plasoprotein called haptoglobin binds to any free hemoglobin to safely transport it.

But in a severe reaction, the haptoglobin is completely saturated.

It just can't handle the load.

Which leaves free hemoglobin just floating everywhere in the blood.

And that excess free hemoglobin triggers a lethal triad of renal shutdown.

It happens in three distinct mechanisms.

First, the intense antigen antibody reaction releases toxic substances from the dying red blood cells.

What do those toxins do?

These toxins cause powerful renal vasoconstriction.

The blood vessels feeding the kidneys violently clamp down, starving them of blood flow.

So the kidney's supply line is cut off?

What's the second mechanism?

Second, the massive loss of circulating red blood cells combined with those same immune toxins causes systemic circulatory shock.

The patient's overall arterial blood pressure plummets.

So even if the kidney's vessels weren't clamped down, there wouldn't be enough pressure to push blood through them anyway?

Exactly.

And the third mechanism is the physical blockade.

Right, the plumbing issue.

This is the most direct damage.

That excess free hemoglobin we talked about leaks through the glomerular membranes directly into the kidney tubules.

As the kidneys try to do their normal job of reabsorbing water, the hemoglobin concentration in those microscopic tubes gets higher and higher.

Until it gets stuck.

Until it reaches a tipping point where it literally precipitates.

It turns from a dissolved liquid into a solid sludge, physically blocking the microscopic tubes of the kidney.

So you have vasoconstriction starving the kidney, circulatory shock, dropping the pressure, and a solid sludge of hemoglobin blocking the plumbing.

Together, they cause acute renal shutdown.

Yes.

And without medical intervention, like an artificial kidney or dialysis, the patient will die within 7 to 12 days.

The precision of the body's defense mechanisms ultimately becomes its own undoing.

It really does.

Which really brings us to the ultimate question.

If a single mismatched protein on a red blood cell can completely shut down the kidneys and end a life, what happens when we scale up?

What happens when doctors try to transplant an entire solid organ with its millions of complex tissue cells into a new body?

As you would expect, the immune system scales up its response accordingly.

And the terminology we use depends on where the tissue comes from.

Right.

If you move tissue from one part of a person's body to another, like a skin graft for a burn, it's an autograft.

If the graft comes from an identical twin, it's an isograft.

Okay, those are the safe ones.

Exactly.

If it comes from another human being, which is the most common scenario for organs, it's an allograft.

And if it comes from an animal, like a pig valve, it's a xenograft.

With autografts and isografts, the tissue survives perfectly because the immune system recognizes the cells as self.

But with allografts and xenografts, the immune system will ruthlessly attack and kill the foreign cells within days to weeks.

It's inevitable.

And the primary target they're looking at isn't the OAB system anymore, it's the HLA complex.

Yes, the human leukocyte antigens.

While red blood cells have the OAB antigens, these HLAs are present on all the solid tissue cells and white blood cells in your body.

And the complexity of the HLA system is staggering.

There are about 150 different HLAs to choose from, and every person has six of them prominently displayed on their cell membranes.

Which creates an astronomical number of combinations.

Right, over one trillion possible combinations.

It is essentially an unhackable biological barcode making a perfect match statistically impossible outside of identical twins.

Because finding a perfect biological barcode match is impossible, transplantation therapy has to focus entirely on suppressing the recipient's immune system.

Specifically, the medical field targets the T cells.

Because they're the ones leading the attack.

Right, they are the specialized immune cells that act as the primary killers of grafted foreign cells.

The textbook details four main pharmacological methods to achieve this suppression, and the mechanisms behind them are fascinating.

Let's run through them.

How exactly do we stop the T cells from attacking the new organ?

The first method uses glucocorticoid hormones.

These drugs work at the genetic level.

They inhibit the specific genes that code for cytokines, especially a signaling molecule called interleukin -2.

What does IL -2 do?

Since IL -2 is the essential signal that tells T cells to proliferate and attack, blocking it stars the T cells of their marching orders.

They never multiply.

The second method sounds a bit more brutal.

Toxic drugs.

Yes, drugs like azathioprine.

These are essentially systemic poisons that target rapidly dividing cells.

They suppress the entire lymphoid system, physically blocking the formation of new antibodies and T cells.

So it works, but...

It is effective, but it is a sledgehammer approach.

Which is why the third method is considered such a massive breakthrough, right?

Drugs like cyclosporine and tacrolimus.

Exactly.

These are calcineurin inhibitors and they act more like a sniper.

Instead of nuking the entire immune system, they inhibit a specific enzyme called calcineurin, which is required for T cell activation.

Oh, that's...

They selectively shut down the T cell's ability to reject the organ while leaving other parts of the immune system relatively intact.

It makes them incredibly valuable in modern transplant medicine.

And the fourth method is using targeted immunosuppressive antibodies, where doctors literally inject specific antibodies designed to hunt down and neutralize the patient's own lymphocytes or block the receptors directly.

But despite all these incredible chemical tools, there is always a tragic trade -off.

Yeah.

By intentionally suppressing the T cells to save the transplanted harder kidney, you are intentionally dismantling the patient's biological fortress.

You leave the patient highly vulnerable to bacterial and viral infections that a normal immune system would easily clear.

And it isn't just infections from the outside.

The textbook notes that the incidence of cancer is several times greater in an immunosuppressed person.

Yes, it is.

Because a normally functioning immune system isn't just fighting bacteria, it is constantly hunting down and destroying our own early cancer cells before they can multiply into tumors.

It leaves the medical field in a very difficult philosophical space.

The immune system's absolute vigilance is the exact thing that causes a life -saving transplant to be rejected.

But suppressing that vigilance leads to rampant infections and aggressive cancers.

It really makes you wonder if we are fighting the wrong battle.

Are we so focused on dismantling the fortress walls that we are missing a better solution?

It begs a really provocative question.

What's that?

Is the ultimate future of transplantation medicine really about finding better, more targeted ways to suppress the immune system?

Or is it about finding a way to perfectly reprogram our biological barcodes, manipulating the genetics of a donor organ so the recipient's body looks at it and genuinely sees it as self?

If we could forge a perfect, identical key for the gates, we wouldn't need to tear down the walls at all.

That is definitely something to mull over the next time you think about what is flowing through your veins.

Thank you so much for tuning in on your medical physiology journey.

On behalf of the Last Minute Lecture team, good luck with Chapter 36 and keep asking the big questions.